Hovione
Sónia Amaral has over 20 years of work experience in the pharmaceutical industry. Sónia started their career as a Trainee at the Analytical Research and Development Laboratory at Hovione FarmaCiencia in 1997. Sónia then became a Quality Control Technical Expert at Hovione from 1997 to 2006. In 2006, they joined Iberfar as the Head of Quality Control. Sónia returned to Hovione in 2008 and held various positions, including Head of Quality Control Pharma Operations and Director of Analytical Chemistry - R&D. Sónia was most recently the Director of Central Quality Control at Hovione. Overall, Sónia has extensive experience in quality control and analytical chemistry roles within the pharmaceutical industry.
From 1994 to 1998, Sónia Amaral attended Faculdade de Ciências da Universidade de Lisboa for an unspecified degree and field of study.
This person is not in any offices
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.